Table of Contents Executive Summary 1 Industry Overview of Ureter Cancer Drugs 1.1 Definition of Ureter Cancer Drugs 1.2 Ureter Cancer Drugs Segment by Type 1.2.1 Global Ureter Cancer Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Durvalumab 1.2.3 Eribulin Mesylate 1.2.4 Pembrolizumab 1.2.5 Others 1.3 Ureter Cancer Drugs Segment by Applications 1.3.1 Global Ureter Cancer Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 In-Patient 1.3.3 Out-Patient 1.4 Global Ureter Cancer Drugs Overall Market 1.4.1 Global Ureter Cancer Drugs Revenue (2014-2025) 1.4.2 Global Ureter Cancer Drugs Production (2014-2025) 1.4.3 North America Ureter Cancer Drugs Status and Prospect (2014-2025) 1.4.4 Europe Ureter Cancer Drugs Status and Prospect (2014-2025) 1.4.5 China Ureter Cancer Drugs Status and Prospect (2014-2025) 1.4.6 Japan Ureter Cancer Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Ureter Cancer Drugs Status and Prospect (2014-2025) 1.4.8 India Ureter Cancer Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Ureter Cancer Drugs 2.3 Manufacturing Process Analysis of Ureter Cancer Drugs 2.4 Industry Chain Structure of Ureter Cancer Drugs 3 Development and Manufacturing Plants Analysis of Ureter Cancer Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Ureter Cancer Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Ureter Cancer Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Ureter Cancer Drugs Production and Capacity Analysis 4.2 Ureter Cancer Drugs Revenue Analysis 4.3 Ureter Cancer Drugs Price Analysis 4.4 Market Concentration Degree 5 Ureter Cancer Drugs Regional Market Analysis 5.1 Ureter Cancer Drugs Production by Regions 5.1.1 Global Ureter Cancer Drugs Production by Regions 5.1.2 Global Ureter Cancer Drugs Revenue by Regions 5.2 Ureter Cancer Drugs Consumption by Regions 5.3 North America Ureter Cancer Drugs Market Analysis 5.3.1 North America Ureter Cancer Drugs Production 5.3.2 North America Ureter Cancer Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Ureter Cancer Drugs Import and Export 5.4 Europe Ureter Cancer Drugs Market Analysis 5.4.1 Europe Ureter Cancer Drugs Production 5.4.2 Europe Ureter Cancer Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Ureter Cancer Drugs Import and Export 5.5 China Ureter Cancer Drugs Market Analysis 5.5.1 China Ureter Cancer Drugs Production 5.5.2 China Ureter Cancer Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Ureter Cancer Drugs Import and Export 5.6 Japan Ureter Cancer Drugs Market Analysis 5.6.1 Japan Ureter Cancer Drugs Production 5.6.2 Japan Ureter Cancer Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Ureter Cancer Drugs Import and Export 5.7 Southeast Asia Ureter Cancer Drugs Market Analysis 5.7.1 Southeast Asia Ureter Cancer Drugs Production 5.7.2 Southeast Asia Ureter Cancer Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Ureter Cancer Drugs Import and Export 5.8 India Ureter Cancer Drugs Market Analysis 5.8.1 India Ureter Cancer Drugs Production 5.8.2 India Ureter Cancer Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Ureter Cancer Drugs Import and Export 6 Ureter Cancer Drugs Segment Market Analysis (by Type) 6.1 Global Ureter Cancer Drugs Production by Type 6.2 Global Ureter Cancer Drugs Revenue by Type 6.3 Ureter Cancer Drugs Price by Type 7 Ureter Cancer Drugs Segment Market Analysis (by Application) 7.1 Global Ureter Cancer Drugs Consumption by Application 7.2 Global Ureter Cancer Drugs Consumption Market Share by Application (2014-2019) 8 Ureter Cancer Drugs Major Manufacturers Analysis 8.1 Altor BioScience Corp 8.1.1 Altor BioScience Corp Ureter Cancer Drugs Production Sites and Area Served 8.1.2 Altor BioScience Corp Product Introduction, Application and Specification 8.1.3 Altor BioScience Corp Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Eisai Co Ltd 8.2.1 Eisai Co Ltd Ureter Cancer Drugs Production Sites and Area Served 8.2.2 Eisai Co Ltd Product Introduction, Application and Specification 8.2.3 Eisai Co Ltd Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Exelixis Inc 8.3.1 Exelixis Inc Ureter Cancer Drugs Production Sites and Area Served 8.3.2 Exelixis Inc Product Introduction, Application and Specification 8.3.3 Exelixis Inc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 GlaxoSmithKline Plc 8.4.1 GlaxoSmithKline Plc Ureter Cancer Drugs Production Sites and Area Served 8.4.2 GlaxoSmithKline Plc Product Introduction, Application and Specification 8.4.3 GlaxoSmithKline Plc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 MedImmune LLC 8.5.1 MedImmune LLC Ureter Cancer Drugs Production Sites and Area Served 8.5.2 MedImmune LLC Product Introduction, Application and Specification 8.5.3 MedImmune LLC Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Merck & Co Inc 8.6.1 Merck & Co Inc Ureter Cancer Drugs Production Sites and Area Served 8.6.2 Merck & Co Inc Product Introduction, Application and Specification 8.6.3 Merck & Co Inc Ureter Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 9 Development Trend of Analysis of Ureter Cancer Drugs Market 9.1 Global Ureter Cancer Drugs Market Trend Analysis 9.1.1 Global Ureter Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Ureter Cancer Drugs Regional Market Trend 9.2.1 North America Ureter Cancer Drugs Forecast 2019-2025 9.2.2 Europe Ureter Cancer Drugs Forecast 2019-2025 9.2.3 China Ureter Cancer Drugs Forecast 2019-2025 9.2.4 Japan Ureter Cancer Drugs Forecast 2019-2025 9.2.5 Southeast Asia Ureter Cancer Drugs Forecast 2019-2025 9.2.6 India Ureter Cancer Drugs Forecast 2019-2025 9.3 Ureter Cancer Drugs Market Trend (Product Type) 9.4 Ureter Cancer Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Ureter Cancer Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Ureter Cancer Drugs Table Global Ureter Cancer Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Ureter Cancer Drugs Production Market Share by Types in 2018 Figure Durvalumab Product Picture Figure Eribulin Mesylate Product Picture Figure Pembrolizumab Product Picture Figure Others Product Picture Table Global Ureter Cancer Drugs Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Ureter Cancer Drugs Consumption Market Share by Applications in 2018 Figure In-Patient Figure Out-Patient Figure Global Ureter Cancer Drugs Revenue (Million USD) (2014-2025) Figure Global Ureter Cancer Drugs Production (K Pcs) (2014-2025) Figure North America Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Figure Europe Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Figure China Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Figure Japan Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Figure India Ureter Cancer Drugs Market Size (Million USD) (2014-2025) Table Ureter Cancer Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Ureter Cancer Drugs in 2018 Figure Manufacturing Process Analysis of Ureter Cancer Drugs Figure Industry Chain Structure of Ureter Cancer Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Ureter Cancer Drugs Manufacturing Plants Distribution Table Ureter Cancer Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Ureter Cancer Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Ureter Cancer Drugs Production (K Pcs) of Major Manufacturers (2014-2019) Table Ureter Cancer Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Ureter Cancer Drugs Production Share by Manufacturers in 2018 Table Ureter Cancer Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Ureter Cancer Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Ureter Cancer Drugs Revenue Share by Manufacturers in 2018 Table Ureter Cancer Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Ureter Cancer Drugs Production by Regions 2014-2019 (K Pcs) Table Global Ureter Cancer Drugs Production Market Share by Regions 2014-2019 Figure Global Ureter Cancer Drugs Production Market Share by Regions in 2018 Table Global Ureter Cancer Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Ureter Cancer Drugs Revenue Market Share by Regions 2014-2019 Figure Global Ureter Cancer Drugs Revenue Market Share by Regions in 2018 Table Global Ureter Cancer Drugs Consumption by Regions 2014-2019 (K Pcs) Table Global Ureter Cancer Drugs Consumption Market Share by Regions 2014-2019 Figure North America Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure North America Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure Europe Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Europe Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure China Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure China Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure Japan Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Japan Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure India Ureter Cancer Drugs Production Growth Rate 2014-2019 (K Pcs) Figure India Ureter Cancer Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Ureter Cancer Drugs Production, Consumption Import and Export (K Pcs) Figure Global Consumption Ureter Cancer Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Ureter Cancer Drugs Market Share by Application (2014-2019) Table Altor BioScience Corp Ureter Cancer Drugs Production Sites and Area Served Table Altor BioScience Corp Ureter Cancer Drugs Product Introduction, Application and Specification Table Altor BioScience Corp Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Altor BioScience Corp Ureter Cancer Drugs Production Growth Rate (2014-2019) Table Altor BioScience Corp Ureter Cancer Drugs Production Market Share (2014-2019) Figure Altor BioScience Corp Ureter Cancer Drugs Revenue Market Share (2014-2019) Table Altor BioScience Corp Ureter Cancer Drugs Main Business and Markets Served Table Eisai Co Ltd Ureter Cancer Drugs Production Sites and Area Served Table Eisai Co Ltd Ureter Cancer Drugs Product Introduction, Application and Specification Table Eisai Co Ltd Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Eisai Co Ltd Ureter Cancer Drugs Production Growth Rate (2014-2019) Table Eisai Co Ltd Ureter Cancer Drugs Production Market Share (2014-2019) Figure Eisai Co Ltd Ureter Cancer Drugs Revenue Market Share (2014-2019) Table Eisai Co Ltd Ureter Cancer Drugs Main Business and Markets Served Table Exelixis Inc Ureter Cancer Drugs Production Sites and Area Served Table Exelixis Inc Ureter Cancer Drugs Product Introduction, Application and Specification Table Exelixis Inc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Exelixis Inc Ureter Cancer Drugs Production Growth Rate (2014-2019) Table Exelixis Inc Ureter Cancer Drugs Production Market Share (2014-2019) Figure Exelixis Inc Ureter Cancer Drugs Revenue Market Share (2014-2019) Table Exelixis Inc Ureter Cancer Drugs Main Business and Markets Served Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Sites and Area Served Table GlaxoSmithKline Plc Ureter Cancer Drugs Product Introduction, Application and Specification Table GlaxoSmithKline Plc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Growth Rate (2014-2019) Table GlaxoSmithKline Plc Ureter Cancer Drugs Production Market Share (2014-2019) Figure GlaxoSmithKline Plc Ureter Cancer Drugs Revenue Market Share (2014-2019) Table GlaxoSmithKline Plc Ureter Cancer Drugs Main Business and Markets Served Table MedImmune LLC Ureter Cancer Drugs Production Sites and Area Served Table MedImmune LLC Ureter Cancer Drugs Product Introduction, Application and Specification Table MedImmune LLC Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table MedImmune LLC Ureter Cancer Drugs Production Growth Rate (2014-2019) Table MedImmune LLC Ureter Cancer Drugs Production Market Share (2014-2019) Figure MedImmune LLC Ureter Cancer Drugs Revenue Market Share (2014-2019) Table MedImmune LLC Ureter Cancer Drugs Main Business and Markets Served Table Merck & Co Inc Ureter Cancer Drugs Production Sites and Area Served Table Merck & Co Inc Ureter Cancer Drugs Product Introduction, Application and Specification Table Merck & Co Inc Ureter Cancer Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Merck & Co Inc Ureter Cancer Drugs Production Growth Rate (2014-2019) Table Merck & Co Inc Ureter Cancer Drugs Production Market Share (2014-2019) Figure Merck & Co Inc Ureter Cancer Drugs Revenue Market Share (2014-2019) Table Merck & Co Inc Ureter Cancer Drugs Main Business and Markets Served Figure Global Ureter Cancer Drugs Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Ureter Cancer Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Ureter Cancer Drugs Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Ureter Cancer Drugs Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Ureter Cancer Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Ureter Cancer Drugs by Type (2019-2025) Table Global Consumption (K Pcs) of Ureter Cancer Drugs by Application (2019-2025) Table Ureter Cancer Drugs Distributors List Table Ureter Cancer Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Altor BioScience Corp Eisai Co Ltd Exelixis Inc GlaxoSmithKline Plc MedImmune LLC Merck & Co Inc